Patients experiencing inadequate appetite suppression after reaching maintenance doses should undergo comprehensive evaluation for factors that may impair treatment response, including medication interactions, adherence issues, or underlying medical conditions requiring additional intervention
The guideline addresses the evaluation, management, and monitoring of individuals with lipid disorders, including high blood cholesterol, hypertriglyceridemia, and elevated Lp(a), incorporating new and updated recommendations based on clinical evidence through late 2024
The legal team at King Law is well-versed in Zepbound eye side effect lawsuits and will work with you to determine the best course of action, considering the circumstances of your case
Warning: The product should not be taken by people with hypersensitivity to any of the constituents of the preparation